New inhaled drug RCS-21 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage trial is checking if a single inhaled dose of RCS-21 is safe and tolerable in 24 healthy adults aged 18 to 64. Participants receive one dose and are closely monitored for side effects. The study does not aim to treat any disease, just to gather initial safety and…
Phase: PHASE1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated May 17, 2026 00:44 UTC